This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Bipolar Disorder
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The objective of this retrospective observational study is to compare commonly prescribed bipolar disorder medications for their impact on: (1) hospitalization; (2) suicide attempts and self-harm; and (3) risk of drug-induced adverse effects such as kidney disease and diabetes mellitus. In addition, the investigators will examine heterogeneity of treatment effect by co-morbidity within pediatric, adult, and elderly sub-populations. Patient focus groups are convened to elicit additional questions and provide feedback on results.

Provided treatments

  • Drug: Lithium Carbonate
  • Drug: Lamotrigine
  • Drug: Valproic Acid
  • Drug: Oxcarbazepine
  • Drug: Carbamazepine
  • Drug: Ziprasidone
  • Drug: Risperidone
  • Drug: Quetiapine
  • Drug: Olanzapine
  • Drug: Aripiprazole
  • Drug: Fluoxetine / Olanzapine
  • Drug: Haloperidol
  • Drug: Perphenazine
  • Drug: Clozapine
  • Drug: Asenapine
  • Drug: Lurasidone
  • Drug: Paliperidone
  • Drug: Mirtazapine
  • Drug: Bupropion
  • Drug: Desvenlafaxine
  • Drug: Duloxetine
  • Drug: Venlafaxine
  • Drug: Citalopram
  • Drug: Escitalopram
  • Drug: Fluoxetine
  • Drug: Fluvoxamine
  • Drug: Paroxetine
  • Drug: Sertraline
  • Drug: Vilazodone
  • Drug: Doxepin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02893371. The sponsor of the trial is University of New Mexico and it is looking for 1037352 volunteers for the current phase.
Official trial title:
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies